Norwegian Underwater Intervention (NUI)   Report issue

Academic/Hospital Phase 4
Founded: Laksevåg Norway (1976)

Organization Overview

First Clinical Trial
2020
NCT04149379
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Norwegian Underwater Intervention (NUI)

Active Ingredients

Drugs in Phase 4 Trials (1)

oxygen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1